{"schema_version":"secwatch.filing_event.v1","accession":"0001609550-23-000008","form_type":"8-K","ticker":"INSP","cik":"0001609550","company_name":"Inspire Medical Systems, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.815226+00:00","generated_at":"2026-06-20T17:52:16.709027+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Inspire Medical Q4 preliminary revenue ~$137.7M (+76% YoY); FY22 ~$407.7M (+75%)","bullets":["Q4 2022 preliminary revenue $137.5M-$137.9M, ~76% YoY increase.","Full-year 2022 revenue $407.5M-$407.9M, ~75% increase over FY 2021.","Activated 61 new U.S. implant centers in Q4 (total 905); added 16 sales territories (total 225).","European revenue growth driven by Germany, Switzerland, and the Netherlands.","Published inaugural Environmental, Social, and Governance (ESG) report."],"urls":{"canonical":"https://secwatch.observer/filing/0001609550-23-000008","json":"https://secwatch.observer/filing/0001609550-23-000008.json","markdown":"https://secwatch.observer/filing/0001609550-23-000008.md","text":"https://secwatch.observer/filing/0001609550-23-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/0001609550-23-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/insp-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:52:16.709027+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0bb6e9fab30c29cfc358fa173cc7a84ec16521c4","claim":"Inspire Medical Systems, Inc. reported preliminary financial results for quarter and full year ended December 31, 2022.","evidence_excerpt":"On January 9, 2023, Inspire Medical Systems, Inc. (the “Company”) issued a press release announcing certain preliminary and unaudited results for the quarter and full year ended December 31, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1609550/000160955023000008/0001609550-23-000008-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter and full year ended December 31, 2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}